NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...

Ambient scribe company Abridge, partnering with Highmark Health, says it can give information on prior authorization during, ...

Pfizer said its antibody-drug conjugate Padcev extended survival when combined with the immunotherapy Keytruda in some ...

Even after Chris Sanford lost 130 pounds, he struggled with body dysmorphia. Every time he looked at the streamlined bodies ...

The inclusion of pregnant participants in RCTs has remained flat over the past 15 years. Changing this norm will require ...

If we don’t act now, we’ll lose one of the most efficient, cost-effective access points in the U.S. health care system,” ...

Vinay Prasad is back at the FDA, and in a position in which grappling with nuance — not always his strong suit — will be the ...

Specifically, the latest guidelines say that researchers should not use any stem cell-based embryo models to try to start a ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

He could appeal the decision to the director of the NIH, Dr. Jay Bhattacharya. It was a name Garber knew exceptionally well. For more than three decades, Garber had nurtured Bhattacharya’s career, ...

A small study finds that an off-the-shelf vaccine candidate by Elicio Therapeutics boosted immune response in pancreatic ...